PHARMA MAR, S.A. «12345...» Página 1 de 18 desde 01/07/1988 hasta 26/09/2024 22/01/2020 08:21 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Pharma Mar announces fulfillment of the condition consisting on the authorization by the United States antitrust authorities to the exclusive license agreement entered with Jazz Pharmaceuticals. Número de registro: 286053 Relacionado con 284941 del 19/12/2019 (13:58) 21/01/2020 17:16 PHARMA MAR, S.A. Composition of other management and supervisory bodies The Company informs of the appointment of Mr. Carlos Pazos Campos as a member of the Appointments and Compensation Committee. Número de registro: 286047 08/01/2020 17:50 PHARMA MAR, S.A. Liquidity contracts and specialists The Company reports details of the operations of the Liquidity Agreement between 01/10/2019 and 31/12/2019 Número de registro: 285701 Relacionado con 266399 del 04/06/2018 (17:39) 19/12/2019 13:58 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks. - Announcements of public presentations and meetings Pharma Mar and Jazz Pharmaceuticals have entered into an exclusive license agreement to commercialize lurbinectedin in the United States. Número de registro: 284941 Relacionado con 286053 del 22/01/2020 (08:21) 17/12/2019 08:10 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Phama Mar submits New Drug Application for lurbinectedin under accelerated approval in small cell lung cancer in the USA. Número de registro: 284566 Relacionado con 281246 del 19/08/2019 (08:27) 23/10/2019 18:49 PHARMA MAR, S.A. Composition of other management and supervisory bodies The Company reports the appointment of the Chairman of the Audit Committee. Número de registro: 282799 23/10/2019 18:32 PHARMA MAR, S.A. Information on P&L The Company sends press release regarding the third quarter 2019 results. Número de registro: 282796 23/10/2019 18:23 PHARMA MAR, S.A. Interim financial information La sociedad remite información sobre los resultados del tercer trimestre de 2019 Número de registro: 282795 03/10/2019 17:51 PHARMA MAR, S.A. Liquidity contracts and specialists The Company reports details of the operations of the Liquidity Agreement between 01/07/2019 and 30/09/2019 Número de registro: 282269 Relacionado con 266399 del 04/06/2018 (17:39) 26/08/2019 08:29 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Pharma Mar and Janssen have entered into a new licensing agreement for Yondelis in US and a master product transfer agreement regarding Yondelis rights in the rest of territories licensed to Janssen. Número de registro: 281299 Página 1 de 18 «12345...»